Triazolyl tropane derivatives

Details Triazolyl tropane derivatives Triazolyl tropane derivatives

2011-04-26

2011-04-26

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S050000, C514S304000, C546S125000

Reexamination Certificate

active

07932235

ABSTRACT:
This invention relates to novel triazolyl tropane derivatives, their acceptable acid addition salts, solvates, hydrates and polymorphs thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by blocking or reducing the binding ability of the CCR5 receptor.

REFERENCES:
patent: 5846514 (1998-12-01), Foster et al.
patent: 6221335 (2001-04-01), Foster
patent: 6440710 (2002-08-01), Keinan et al.
patent: 6603008 (2003-08-01), Ando et al.
patent: 6667314 (2003-12-01), Perros et al.
patent: 7517990 (2009-04-01), Ito et al.
patent: 2007/0082929 (2007-04-01), Gant et al.
patent: 2007/0197695 (2007-08-01), Potyen et al.
patent: 2008/0103122 (2008-05-01), Veltri
patent: 2008/0146605 (2008-06-01), Gant et al.
patent: WO-95/26325 (1995-10-01), None
patent: WO-01/90106 (2001-11-01), None
patent: WO-03/084954 (2003-10-01), None
Koenig et al., Biochemistry, 1999, vol. 38, pp. 6327-6334.
Price et al., “Initial synthesis of UK-427,857 (Maraviroc)”, Tetrahedron Letters 46 (2005), pp. 5005-5007.
Hughes, et al., “New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir”, Expert Opinion Pharmacother (2009), 10 (15), pp. 1-22.
Walker, et al., “Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV”, Drug Metabolism and Disposition, vol. 33, No. 4, 2005, pp. 587-595.
Kushner, D.J. et al: “Pharmacological Uses and Perspectives of Heavy Water and Deuterated Compounds,” Can. J. Physiol. Pharmacol 77: 79-88 (1999).
International Search Report in corresponding PCT International Application No. PCT/US2007/024167.
International Preliminary Report on Patentability in corresponding PCT International Application No. PCT/US2007/024167.
Browne, T.R., Journal of Clinical Pharmacology 38: 213-220 (1998).
Baillie, T.A., Pharmacology Rev. 33:81-132 (1981).
Gouyette, A., Biomedical and Environmental Mass Spectrometry, vol. 15, 243-247 (1988).
Cherrah, Y. et al., Biomedical and Environmental Mass Spectrometry, vol. 14, Issue 11, pp. 653-657 (1987).
Dyck, L.E. et al., Journal of Neurochemistry, vol. 46, Issue 2, pp. 399-404 (1986).
Tonn, G.R., et al., Biological Mass Spectrometry, vol. 22, Issue 11, pp. 633-642 (1993).
Haskins, N.J., Biomedical Spectrometry, vol. 9, Issue 7, pp. 269-277 (1982).
Wolen, R.L., J. Clin. Pharmacology 26: 419-424 (1986).
Pieniaszek, H.J. et al., J. Clin. Pharmacol. 39:817-825 (1999).
Honma, S. et al., Drug Metab Dispos 15(4): 551 (1987).
Foster, A.B., Adv Drug Res, 14:1-40 (1985).
Fisher, M.B. et al., Current Opinion in Drug Discovery & Development 9:101-09 (2006).
Foster, A.B., “Deuterium isotope effects in studies of drug metabolism”, TIPS 524-527 (Dec. 1984).

Affiliated with

Also associated with

Rating

Triazolyl tropane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolyl tropane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolyl tropane derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2631165